Pursue Wealth Partners LLC Has $1.24 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Pursue Wealth Partners LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 17.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,846 shares of the exchange traded fund’s stock after buying an additional 2,060 shares during the quarter. Pursue Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,236,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. EPG Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 152.7% in the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after purchasing an additional 278 shares during the period. Tennessee Valley Asset Management Partners acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $44,000. Wetzel Investment Advisors Inc. acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $45,000. Sheets Smith Wealth Management acquired a new stake in SPDR S&P Biotech ETF in the third quarter worth about $55,000. Finally, Life Planning Partners Inc acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $64,000.

SPDR S&P Biotech ETF Stock Up 1.5 %

XBI stock traded up $1.27 during midday trading on Friday, reaching $83.49. The stock had a trading volume of 10,452,779 shares, compared to its average volume of 11,723,970. The business has a fifty day simple moving average of $92.69 and a two-hundred day simple moving average of $84.72. The firm has a market cap of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.